- Home
- Publications
- Publication Search
- Publication Details
Title
Apremilast in psoriasis - a prospective real-world study
Authors
Keywords
-
Journal
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
Volume 32, Issue 2, Pages 254-259
Publisher
Wiley
Online
2017-09-19
DOI
10.1111/jdv.14598
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Real-World Experience With Apremilast in Treating Psoriasis
- (2016) Julia N. Mayba et al. JOURNAL OF CUTANEOUS MEDICINE AND SURGERY
- The infliximab biosimilar in the treatment of moderate to severe plaque psoriasis
- (2016) Paolo Dapavo et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in patients with moderate-to-severe plaque psoriasis over 52 weeks: a phase III, randomized controlled trial (ESTEEM 2)
- (2015) C. Paul et al. BRITISH JOURNAL OF DERMATOLOGY
- Long-Term Efficacy, Safety and Drug Survival of Ustekinumab in a Spanish Cohort of Patients with Moderate to Severe Plaque Psoriasis
- (2015) Lluís Puig et al. DERMATOLOGY
- Differential Drug Survival of Biologic Therapies for the Treatment of Psoriasis: A Prospective Observational Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR)
- (2015) Richard B. Warren et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Longterm (52-week) Results of a Phase III Randomized, Controlled Trial of Apremilast in Patients with Psoriatic Arthritis
- (2015) A. Kavanaugh et al. JOURNAL OF RHEUMATOLOGY
- Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: Results of a phase III, randomized, controlled trial (Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis [ESTEEM] 1)
- (2015) Kim Papp et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- The Pharmacodynamic Impact of Apremilast, an Oral Phosphodiesterase 4 Inhibitor, on Circulating Levels of Inflammatory Biomarkers in Patients with Psoriatic Arthritis: Substudy Results from a Phase III, Randomized, Placebo-Controlled Trial (PALACE 1)
- (2015) Peter H. Schafer et al. Journal of Immunology Research
- Immunology of Psoriasis
- (2014) Michelle A. Lowes et al. Annual Review of Immunology
- The impact of co-administration of ketoconazole and rifampicin on the pharmacokinetics of apremilast in healthy volunteers
- (2014) Yong Liu et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Acquired resistance to TKIs in solid tumours: learning from lung cancer
- (2014) D. Ross Camidge et al. Nature Reviews Clinical Oncology
- Determinants of drug survival for etanercept in a long-term daily practice cohort of patients with psoriasis
- (2013) J.M.P.A. van den Reek et al. BRITISH JOURNAL OF DERMATOLOGY
- Th17 and Th22 cells in psoriatic arthritis and psoriasis
- (2013) Helen Benham et al. ARTHRITIS RESEARCH & THERAPY
- German S3-guidelines on the treatment of psoriasis vulgaris (short version)
- (2012) A. Nast et al. ARCHIVES OF DERMATOLOGICAL RESEARCH
- BRAF Inhibitors for the Treatment of Metastatic Melanoma: Clinical Trials and Mechanisms of Resistance
- (2012) A. M. Alcala et al. CLINICAL CANCER RESEARCH
- The roles of cells and cytokines in the pathogenesis of psoriasis
- (2012) Susana Coimbra et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Comparison of drug survival rates for adalimumab, etanercept and infliximab in patients with psoriasis vulgaris
- (2011) R. Gniadecki et al. BRITISH JOURNAL OF DERMATOLOGY
- Alterations in cyclic nucleotide phosphodiesterase activities in omental and subcutaneous adipose tissues in human obesity
- (2011) B Omar et al. Nutrition & Diabetes
- Switching from etanercept to adalimumab is effective and safe: results in 30 patients with psoriasis with primary failure, secondary failure or intolerance to etanercept
- (2010) P.P.M. Van Lümig et al. BRITISH JOURNAL OF DERMATOLOGY
- Interleukin (IL)-22, IL-17, IL-23, IL-8, vascular endothelial growth factor and tumour necrosis factor-α levels in patients with psoriasis before, during and after psoralen-ultraviolet A and narrowband ultraviolet B therapy
- (2010) S. Coimbra et al. BRITISH JOURNAL OF DERMATOLOGY
- Effect of Obesity on the Pharmacokinetics of Drugs in Humans
- (2010) Michael J. Hanley et al. CLINICAL PHARMACOKINETICS
- Increased expression of IL-12p70 and IL-23 by multiple dendritic cell and macrophage subsets in plaque psoriasis
- (2009) Nikhil Yawalkar et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- European S3-Guidelines on the systemic treatment of psoriasis vulgaris
- (2009) D Pathirana et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Neutrophil Activation in Morbid Obesity, Chronic Activation of Acute Inflammation
- (2009) Jeroen Nijhuis et al. Obesity
- PDE4 inhibitors: current status
- (2008) D Spina BRITISH JOURNAL OF PHARMACOLOGY
- The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: Results from NHANES 2003-2004
- (2008) Shanu Kohli Kurd et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search